Caraco Stockholders Approve Merger With Parent Sun PharmaDetroit-based Caraco Pharmaceutical Laboratories Inc. will shortly cease operation as a publicly traded company.
Caraco Announces $5.25-A-Share Deal With Sun PharmaDetroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Tuesday that it had entered into a merger agreement Monday with Sun Pharmaceutical Industires Ltd., an Indian pharma firm that already owns 75.8 percent of Caraco's stock.
Caraco Loss Flat Despite Lower SalesThe Detroit generic drug maker Caraco Pharmaceutical reported a loss of $3 million or eight cents a share in the third fiscal quarter of its fiscal year, ended Dec. 31, an improvement from a loss of $3.3 million or eight cents a share in the same quarter a year earlier despite a decline in revenue in the quarter to $40.4 million from $52 million a year earlier.
Caraco Sets Independent Committee To Study Buyout OfferA day after receiving a buyout offer from its Indian parent company for the minority of its shares still on the public markets, the Detroit generic drugmaker appoints a group to study the offer
Caraco Gets Sun Pharma Offer To Go PrivateDetroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) has received an offer to go private from its parent company and India.
Caraco Pharmaceutical Names New CEO
Caraco Markets Generic Flomax
Caraco Markets Generic Wellbutrin
Caraco Adds Two Generics